Transparency Market Research (TMR) has published a new report titled, ‘Cardiac Pacemakers Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the global cardiac pacemakers market was valued at US$ 9,514.0 Mn in 2018 and is projected to expand at a CAGR of 7.8% from 2019 to 2027. Overview
Cardiac pacemaker is a tool for the control of cardiac rhythm which controls heart rhythm by transmitting electrical impulses to the heart. It is composed of two components: generator and lead. The cardiac pacemaker market is witnessing substantial growth due to a steady rise in the geriatric population and an increase in cardiovascular disease incidence Growing awareness in countries in Asia is likely to boost demand for cardiac pacemakers in the region. However, rising cost of treatment and strict regulatory process could restrict market growth in the near future. On the other hand, large potential patient base in countries in Asia Pacific is likely to create an opportunity for cardiac pacemaker manufacturers to record high growth in revenue and market share during the forecast period. Increasing usage of MEMS-built pacemaker, due to its cheap and less-invasive features is the growing trend in future. Leadless pacemakers, tele-monitoring and MRI-compatible pacemakers are recently technologically advanced pacemaker which records higher patient safety. The cardiac pacemaker is mainly covered by top three manufacturers and their share in the market is expected to increase in future. Industry would be controlled by large-scale manufacturer who would be willing to invest more on Research and Development. North America dominated the global cardiac pacemakers market in 2018 and the trend is anticipated to continue during the forecast period. Extremely structured health care industry, increased prevalence of cardiovascular disorders are expected to drive the market in North America.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php? flag=B&rep_id=46407 Rising prevalence of disorders such as hypertension, diabetes and obesity to Drive Market
Diabetes, hypertension, and obesity are the leading causes of cardiovascular disorders, especially stenosis, stroke, atresia and regurgitation. The risk of cardiovascular diseases increases when hypertension coexists with diabetes. The America Heart Association estimates that around 16.0 million Americans were diagnosed with diabetes in 2017, and 65% of this patient population is likely to suffer from cardiovascular diseases. Thus, the prevalence of these disorders is constantly rising due to socio-economic factors such as lifestyle-induced dietary and other habits. The WHO estimated that 35% of adults aged 20 years and above were overweight in 2016; globally, obesity has almost doubled since 2000. Furthermore, the prevalence of hypertension was valued at 1 billion in 2016. Moreover, the WHO indicates that, in 2017, the prevalence of hypertension-induced blood pressure in low and middle income countries was 40%, while it was 35% in high income